| Literature DB >> 33953688 |
Diana Simona Antal1, Florina Ardelean1, Robert Jijie1, Iulia Pinzaru2, Codruta Soica3, Cristina Dehelean2.
Abstract
The smoketree (Cotinus coggygria) is a historically known medicinal plant from Southeast Europe. Its ethnomedicinal use in skin and mucosal lesions is commonly accepted across countries. Other utilizations reported locally include fever reduction, cardiac diseases, hypertension, urinary diseases, cough, asthma, hemorrhoids, diabetes, numbness of arm, liver disease, and cancer. Departing from the smoketree's traditional uses, this review summarizes investigations on the phytochemistry and bioactivity of the plant. In vitro and in vivo experiments supporting wound-healing, anti-inflammatory, antibacterial, cytotoxic, antioxidative, hepatoprotective, and antidiabetic effects are presented. Metabolites from smoketree that are responsible for the main pharmacological effects of smoketree are pointed out. Furthermore, the review performs a comparison between C. coggygria and the lacquer tree (Toxicodendron vernicifluum). The latter is a comprehensively studied species used in Asian phytotherapy, with whom the European smoketree shares a consistent pool of secondary metabolites. The comparative approach aims to open new perspectives in the research of smoketree and anticipates an optimized use of C. coggygria in therapy. It also points out the relevance of a chemosystematic approach in the field of medicinal plants research.Entities:
Keywords: Cotinus coggygria; Toxicodendron vernicifluum; common metabolites; fisetin; sulfuretin
Year: 2021 PMID: 33953688 PMCID: PMC8092975 DOI: 10.3389/fphar.2021.662852
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1Representative compounds from the leaves of C. coggygria.
FIGURE 2Structure of condensed tannins from C. coggygria.
FIGURE 3Sulfuretin and its derivatives–typical aurones in C. coggygria wood.
FIGURE 4Representative flavonoids with a 6-membered C-ring from the heartwood of C. coggygria, consistently displaying a hydroxy group in position 7 of the A-ring.
Studies evaluating the anti-inflammatory effect of smoketree extracts and fractions.
| Extract | Experimental model | Results | References |
|---|---|---|---|
| Water extract of erial parts |
| EC50 = 2.21 ± 0.18 mg/ml for COX-1 inhibition; EC50 = 4.10 ± 0.27 mg/ml for COX-2 inhibition; Extract had best results in comparison to that of other 8 medicinal plants |
|
| Heartwood/dietly ether fraction of methanol extract standardized to its content in S, B, fustin, 2,3-dihydroquercetagetin, and quercetin | Mouse ear edema (SKH1 male mice) induced with 12-O-tetradecanoyl phorbol-13-acetate; corneometric assessment | External application of 2 mg extract reduced inflammation with 50%; reduction with 26% of the skin dehydration induced by 12-O-tetradecanoyl phorbol-13-acetate |
|
| Aqueous infusion from | Rats with the carrageenan induced paw edema | Protective effect against inflammation following the intragastric administration of the extract (10 ml/kg) for 15 days |
|
| Young shoots/ethyl acetate fraction of acetone extract | Rats with the carrageenan induced paw edema | Doses of 50 mg/kg and 100 mg/kg reduced theoedema with 46.5 ± 18.5% and 76.7 ± 0.0%, respectively |
|
| Total flavonoids isolated from | Formalin-induced edema in mice | Oral administration of 80–160 mg/kg 2 h before and 5 h after formalin application reduced edema, decreased proliferation of cellular elements and raised capillary resistance |
|
COX: cyclooxygenase; EC50: half maximal effective concentration.
Secondary metabolites occuring both in the heartwoods of Cotinus coggygria (syn. Rhus cotinus) and Toxicodendron vernicifluum (syn. Rhus verniciflua).
| Compound |
|
|
|---|---|---|
| Sulfuretin |
|
|
| Butein |
|
|
| Isoliquiritigenin ( |
|
|
| Eriodictyol |
|
|
| Butin |
|
|
| 3.3″-butindimer |
|
|
| Liquiritigenin (4′,7-dihydroxyflavanone) |
|
|
| Taxifolin |
|
|
| 2,3-Dihydroquercetagetin |
|
|
| 2,3-trans-Fustin |
|
|
| 3- |
| — |
| 3- |
|
|
| Fisetin |
|
|
| Quercetin |
|
|
| 3′,4′,7- trihydroxyflavone |
|
|
| Gallic acid |
|
|
| Methyl gallate |
|
|
| β-resorcylic acid |
|
|
FIGURE 5Benefits of an interconnected approach for an optimized valorization of smoketree.
FIGURE 6Metabolites from smoketree that have been reported to be responsible for the main pharmacological effects of smoketree.